Development and optimization of apigenin-loaded transfersomal system for skin cancer delivery: in vitro evaluation

References

• Abdallah MH. 2013. Transfersomes as a transdermal drug delivery system for enhancement the antifungal activity of Nystatin. Int J Pharm Pharm Sci. 5:560–567.
   Google Scholar
• Ali MS, Alam MS, Alam N, Alam MI, Imam F, Ali MD. 2012. Formulation, characterization and in-vivo study of nanoemulsion topical gel of beclomethasone dipropionate for psoriasis. World J Pharmacy Pharmaceut Sci. 1:839–857.
   Google Scholar
• Alexander A, Saraf S, Saraf S. 2015. A comparative study of chitosan and poloxamer based thermosensitive hydrogel for the delivery of PEGylated melphalan conjugates. Drug Dev Ind Pharm. 41:1954–1961.
   PubMed Web of Science ®Google Scholar
• Cevc G, Blume G. 1992. Lipid vesicles penetrate into intact skin owing to the transdermal osmotic gradients and hydration force. Biochim Biophys Acta. 1104:226–232.
   PubMed Web of Science ®Google Scholar
• Cevc G, Grbauer D, Schatzlein A, Blume G. 1998. Ultraflexible vesicles, transfersomes, have an extremely low pore penetration resistance and transport therapeutic amounts of insulin across the intact mammalian skin. Biochim Biophys Acta. 1368:201–215.
   PubMed Web of Science ®Google Scholar
• Ding S, Zhang Z, Song J, Cheng X, Jiang J, Jia X. 2014. Enhanced bioavailability of apigenin via preparation of a carbon nanopowder solid dispersion. Int J Nanomed. 9:327–2333.
   PubMed Web of Science ®Google Scholar
• Duangjit S, Opanasopit P, Rojanarata T, Ngawhirunpat T. 2011. Characterization and in vitro skin permeation of meloxicam-loaded liposomes versus transfersomes. J Drug Deliv. 2011:418316.
   PubMedGoogle Scholar
• Durán-Lobato M, Martín-Banderas L, Lopes R, Gonçalves LM, Fernández-Arévalo M, Almeida AJ. 2016. Lipid nanoparticles as an emerging platform for cannabinoid delivery: physicochemical optimization and biocompatibility. Drug Dev Ind Pharm. 42:190–198.
   PubMed Web of Science ®Google Scholar
• Elsayed MMA, Abdullah OY, Naggar VF, Khalafallah NM. 2006. Deformable liposomes and ethosomes: mechanism of enhanced skin delivery. Int J Pharm. 322:60–66.
   PubMed Web of Science ®Google Scholar
• Fang YP, Tsai YH, Wu PC, Huang YB. 2008. Comparison of 5-aminolevulinic acid-encapsulated liposome versus ethosome for skin delivery for photodynamic therapy. Int J Pharm. 356:144–152.
   PubMed Web of Science ®Google Scholar
• Gajra B, Patel RR, Dalwadi C. 2016. Formulation, optimization and characterization of cationic polymeric nanoparticles of mast cell stabilizing agent using the Box?Behnken experimental design. Drug Dev Ind Pharm. 42:747–757.
   PubMed Web of Science ®Google Scholar
• Gupta PN, Mishra V, Rawat A, Dubey P, Mahor S, Jain S, Chatterji DP, Vyas SP. 2005. Non-invasive vaccine delivery in transfersomes, niosomes and liposomes: a comparative study. Int J Pharm. 293:73–82.
   PubMed Web of Science ®Google Scholar
• Gupta A, Kaur CD, Saraf S, Saraf S. 2016. Formulation, characterization, and evaluation of ligand-conjugated biodegradable quercetin nanoparticles for active targeting. Artif Cells Nanomed Biotechnol. 44:960–970.
   PubMed Web of Science ®Google Scholar
• Jain S, Jain P, Umamaheshwari RB, Jain NK. 2003. Transfersomes–a novel vesicular carrier for enhanced transdermal delivery: development, characterization, and performance evaluation. Drug Dev Ind Pharm. 29:1013–1026.
   PubMed Web of Science ®Google Scholar
• Jain SK, Jangdey MS. 2009. Lectin conjugated gastro-retentive multiparticulate delivery system of clarithromycin for the effective treatment of Helicobacter pylori. Int J Mol Pharmaceut. 6:295–304.
   PubMed Web of Science ®Google Scholar
• Khan MA, Pandit J, Sultana Y, Sultana S, Ali A, Aqil M, Chauhan M. 2015. Novel carbopol-based transfersomal gel of 5-fluorouracil for skin cancer treatment: in vitro characterization and in vivo study. Drug Deliv. 22:795–802.
   PubMed Web of Science ®Google Scholar
• Kyaw MH, Chun-Chieh C, Lie-Fen S. 2010. Current research and development of chemotherapeutic agents for melanoma. Cancers. 2:397–419.
   PubMedGoogle Scholar
• Mangalathillam S, Rejinold NS, Nair A, Lakshmanan VK, Nair SV, Jayakumar R. 2012. Curcumin loaded chitin nanogels for skin cancer treatment via the transdermal route. Nanoscale. 4:239–250.
   PubMed Web of Science ®Google Scholar
• Mukerje A, Vishwanatha JK. 2009. Characterization and evaluation of curcumin-loaded PLGA nanospheres for cancer therapy. Anticancer Res. 29:3867–3876.
   PubMed Web of Science ®Google Scholar
• Nasr M, Abdel-Hamid S. 2016. Optimizing the dermal accumulation of a tazarotene microemulsion using skin deposition modeling. Drug Dev Ind Pharm. 42:636–643.
   PubMed Web of Science ®Google Scholar
• Palem CR, Dudhipala NR, Battu SK, Repka MA, Rao Yamsani M. 2015. Development, optimization and in vivo characterization of domperidone-controlled release hot-melt-extruded films for buccal delivery. Drug Dev Ind Pharm. 42:473–484.
   PubMed Web of Science ®Google Scholar
• Patel D, Shukla S, Gupta S. 2007. Apigenin and cancer chemoprevention: progress, potential and promise. Int J Oncol. 30:233–245.
   PubMed Web of Science ®Google Scholar
• Patel R, Singh SK, Singh S, Sheth NR, Gendle R. 2009. Development and characterization of curcumin loaded transfersome for transdermal delivery. J Pharm Sci Res. 1:71–80.
   Google Scholar
• Puri R, Mahajan M, Sahajpal NS, Singh H, Singh H, Jain SK. 2015. Self-nanoemulsifying drug delivery system of docosahexanoic acid: development, in vitro, in vivo characterization. Drug Dev Ind Pharm. 42:1032–1041.
   PubMed Web of Science ®Google Scholar
• Ravula R, Herwadker AK, Abla MJ, Little J, Banga AK. 2016. Formulation optimization of a drug in adhesive transdermal analgesic patch. Drug Dev Ind Pharm. 42:862–870.
   PubMed Web of Science ®Google Scholar
• Saraf S, Jeswani G, Kaur CD, Saraf S. 2011. Development of novel herbal cosmetic cream with Curcuma longa extract loaded transfersomes for antiwrinkle effect. Afr J Pharm Pharmacol. 5:1054–1062.
   Google Scholar
• Sarwa KK, Das PJ, Mazumder B. 2014. A nanovesicle topical formulation of Bhut Jolokia (hottest capsicum): a potential anti-arthritic medicine. Expert Opin Drug Deliv. 11:661–676.
   PubMed Web of Science ®Google Scholar
• Shaal A, Shegokar L, Müller RH. 2011. Production and characterization of antioxidant apigenin nanocrystals as a novel UV skin protective formulation. Int J Pharm. 420:133–140.
   PubMed Web of Science ®Google Scholar
• Shen L, Zhang Y, Wang Q, Xu L, Feng NP. 2014. Enhanced in vitro and in vivo skin deposition of apigenin delivered using ethosomes. Int J Pharmaceut. 460:280–288.
   PubMed Web of Science ®Google Scholar
• Tong X, Van Dross RT, Abu-Yousif A, Morrison AR, Pelling JC. 2007. Apigenin prevents UVB-induced cyclooxygenase 2 expression: coupled mRNA stabilization and translational inhibition. Mol Cell Biol. 27:283–296.
   PubMed Web of Science ®Google Scholar
• Walve JR, Bakliwal SR, Rane BR, Pawar SP. 2011. Transfersomes: a syrrogated carrier for transdermal drug delivery system. Int J App Bio Pharm Tech. 2:204–213.
   Google Scholar
• Yousif AO, Smith KA, Getsios S, Green KJ, Van Dross RT, Pelling JC. 2008. Enhancement of UVB-induced apoptosis by apigenin in human keratinocytes and organotypic keratinocyte cultures. Cancer Res. 68:3057–3065.
   PubMed Web of Science ®Google Scholar
• Zhang X, Liu J, Qiao H, Liu H, Ni J, Zhang W, Shi Y. 2010. Formulation optimization of dihydroartemisinin nanostructured lipid carrier using response surface methodology. Powder Technol. 197:120–128.
   Web of Science ®Google Scholar